Efficacy and safety of the mineralocorticoid receptor antagonist treatment for central serous chorioretinopathy: a systematic review and meta-analysis.

Jianan DuanYun ZhangMeixia Zhang

Published in: Eye (London, England) (2021)

Our meta-analysis shows that the MRA treatment can improve anatomical structure in CSC patients, but it is not effective for achieving BCVA gain. The applicant of the MRA is safe and have no severe effect.

Keyphrases

systematic review
end stage renal disease
ejection fraction
high grade
randomized controlled trial
peritoneal dialysis
early onset
magnetic resonance
combination therapy
drug induced
case control